ARMISTICE CAPITAL LLC 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-22 08:14 am Sale | 2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 0 0.000% | -1,490 (Position Closed) | Filing |
| 2020-09-16 4:56 pm Purchase | 2020-09-14 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,490 97.900% | 138 (+10.20%) | Filing |
| 2020-08-20 4:50 pm Purchase | 2020-08-13 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,352 97.700% | 2 (+0.12%) | Filing |
| 2020-04-01 4:22 pm Purchase | 2020-03-25 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 1,350 98.800% | 141 (+11.67%) | Filing |